Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 42Y93 | — |
a one-year-old patient received a dose of Kinrix.; Kinrix administered instead of Infanrix.; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old male patient who received DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis. Co-suspect products included DTPa (Infanrix) for prophylaxis. On 21-JAN-2025, the patient received Kinrix. On an unknown date, the patient did not receive Infanrix. On 21-JAN-2025, an unknown time after receiving Kinrix and not applicable after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: a one-year-old patient received a dose of Kinrix.) and wrong vaccine administered (Verbatim: Kinrix administered instead of Infanrix.). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-JAN-2025 The nurse reported that a one-year-old patient received a dose of Kinrix, which led to inappropriate age at vaccine administration. Reporter mentioned that the intention was to give Infanrix to that patient instead, which led to wrong vaccine administered.